Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device

American Journal of Hospice and Palliative Medicine

Volumn 35, Issue 5, 2018, Pages 812-813

  Smith, Thomas J ^a   Marineo, Giuseppe ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

devices; electrical pain stimulation; neurocutaneous pain stimulation; new therapies for pain; pain; postherpetic neuropathy

Indexed keywords

ADULT; AGED; ANALGESIA; ELECTROTHERAPY; FEMALE; HUMAN; MALE; MIDDLE AGED; POSTHERPETIC NEURALGIA; PROCEDURES;

ADULT; AGED; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MANAGEMENT;

EID: 84921056354     PISSN: 10499091     EISSN: 19382715     Source Type: Journal    
DOI: 10.1177/1049909113494002     Document Type: Article

References (15)

1. Philip A, Thakur R. Post herpetic neuralgia. J Palliat Med. 2011;14(6):765–773.
2. Oxman MN, Levin MJ, Johnson GR, ; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–2284.
3. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;(3):CD007938.
4. Barbarisi M, Pace MC, Passavanti MB. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Clin J Pain. 2010;26(7):567–572.
5. Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003;4(1):1–10.
6. Sabato AF, Marineo G, Gatti A. Calmare therapy. Minerva Anestesiol. 2005;71(7-8):479–482.
7. ®) for chemotherapy induced peripheral neuropathy. J Pain Symptom Manage. 2010;40(6):883–891.
8. Pachman DR, Linquist BM, Barton DL. Pilot study of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. J Clin Oncol. 2012;(suppl; abstr 9075).
9. Ricci M, Pirotti S, Scarpi E. Managing chronic pain: results from an open-label study using MC5-A Calmare® device. Support Care Cancer. 2012;20(2):405–412.
10. Guiseppe M, Vit torio I, Cristiano G, Vincenzo M, Smith TJ. MC5-A Scrambler therapy relieves chronic neuropathic pain more effectively than guideline based drug management. J Pain Symptom Manage. 2012;43(1):87–95.
11. Attal N, Cruccu G, Haanpää M, ; EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153–1169.
12. Ko YK, Lee HY, Lee WY. Clinical experiences on the effect of Scrambler therapy for patients with postherpetic neuralgia. Korean J Pain. 2013;26(1):98–101. doi:10.3344/kjp.2013.26.1.98.
13. Park HS, Sin WK, Kim HY, Moon JY, Park SY, Kim YC, Lee SC. Scrambler therapy for patients with cancer pain—case series. Korean J Pain. 2013;26(1):65–71. doi:10.3344/kjp.2013.26.1.65.
14. Sparadeo F, Kaufman C, D’Amato S. Scrambler therapy: an innovative and effective treatment for chronic neuropathic pain. J Life Care Plan. 2012;11(3):3–15.
15. Harke H, Gretenkorte P, Ulrich L, Koester P, Rahman S. Spinal cord stimulation in post herpetic neuralgia and in acute herpes zoster pain. Anesth Analg. 2002;94(3):694–700.